Monoclonal Antibody Assets for Social Media Distribution
This page contains downloadable assets used in digital advertising for raising awareness about monoclonal antibody (mAb) treatments for COVID-19. You will find these assets in English and Spanish. We have also included recommended responses to comments you may receive from social media users. Please keep in mind that Lilly's name and logo should not be used in any posts created with these assets.
Jump to section:
How to Use These Assets
The assets below were originally used in Eli Lilly and Company’s mAb Treatment Awareness digital advertising campaign. Each of the visuals was used in different combinations with the copy options.
Each creative option can be built in Facebook Ads Manager (for Facebook or Instagram) or Twitter Ads. For example, Creative Option 1 below would be built using both Copy Option A and Copy Option B. The resulting ads would look like:
Facebook Ad 1A (creative 1 with copy A)
Facebook Ad 1B
Instagram Ad 1A
Instagram Ad 1B
Twitter Ad 1A
Twitter Ad 1B
Copy Options come complete with body copy, headlines, link descriptions, and CTAs. (See glossary below for definitions.) Not all of these copy assets are available in each placement type, but they are still provided.
Important Reminder
Please keep in mind that Lilly’s name and logo should not be used in any posts created from these assets.
English Assets
Click link below to download Facebook assets in English.
Click link below to download Instagram assets in English.
Click link below to download Twitter assets in English.
Spanish Assets
Click link to download Facebook assets in Spanish.
Click link to download Instagram assets in Spanish.
Click link to download Twitter assets in Spanish.
Glossary
Ad Components
Creative Considerations
Recommended Responses
Social media posts about COVID-19 naturally generate a lot of questions and comments from the public, so we have developed a list of helpful responses for you to use. Click below to download recommended responses in English and Spanish.
Recommended Responses